ACT Announces Aberdeen Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived ...

30 January 2012, 5:00 am

Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today that the Aberdeen Royal Infirmary, the largest of the Grampian University Hospitals in Scotland, has been confirmed as a site for its Phase 1/2 human clinical trial for Stargardt’s Macular Dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .... Read More »

More Topics from "News"

• Aberdeen dads learning to be better parents thanks to innovative project
• Giant creature found in ocean depths
• Goal: Aberdeen Looks to New Stadium to Reignite Old Firm Challenge
• A Scottish Windfarm Is Causing A Huge Problem For Donald Trump's $1 Billion Golf Course
• Dundee's Rae makes Aberdeen move
• Aberdeen FC Manager unveils BHF Scotland healthy eating initiative at Oldmachar Academy
• US billionaire Trump halts Scotland golf course construction due to 'ugly' wind farm
• Trump in Scotland, all wind, says neighbor
• Dana starts new oil production in Egypt